Navigation Links
Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
Date:4/2/2009

and technical issues; clinical trials, including the DURATION-2 clinical trial mentioned in this press release, not being completed in a timely manner, not confirming previous results, or not achieving the intended clinical endpoints; pre-clinical trials not predicting future results; label expansion requests or New Drug Application ("NDA") filings, including the NDA filing for exenatide once weekly, not being submitted in a timely manner; regulatory approval being delayed or not received; or manufacturing and supply issues. The potential for BYETTA, SYMLIN and/or exenatide once weekly may also be affected by government and commercial reimbursement and pricing decisions, the pace of market acceptance, or scientific, regulatory and other issues and risks inherent in the development and commercialization of pharmaceutical products. These risks also include a potential adverse impact on our financial condition if the steps outlined in this press release to address the change of control provisions in two of our debt agreements are unsuccessful and we are required to repay the amounts outstanding under any of our debt agreements. These and additional risks and uncertainties are described more fully in Amylin's most recent SEC filings including its Annual Report on Form 10-K. Amylin undertakes no duty to update these forward-looking statements.

Additional Information and Where to Find It

This release may be deemed to be solicitation material in respect of the matters to be considered at the 2009 Annual Meeting of Stockholders. Amylin will be filing a proxy statement with the Securities and Exchange Commission ("SEC"). INVESTORS AND SECURITYHOLDERS ARE URGED TO READ THE PROXY STATEMENT, THE BLUE PROXY CARD AND ANY OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and securityholders will be able to receive the proxy statement and other re
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Healthcare Conference
2. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
3. Amylin Pharmaceuticals Reports Third Quarter Financial Results
4. Amylin Pharmaceuticals to Present at BIOCOM Investor Conference
5. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
6. Xenome Receives a Syndicated US$10 Million Equity Investment from Queensland BioCapital Fund, Amylin Pharmaceuticals and Innovis Investment Partners
7. Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program
8. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amylin Pharmaceuticals to Webcast First Quarter Results
10. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
11. Amylin Pharmaceuticals Announces Time Change to Previously Announced Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... N.J. , July 22, 2014 The Board ... BDX ) has declared a quarterly dividend of 54.5 ... holders of record on September 9, 2014. The indicated annual ... About BD BD is a leading medical technology company ... the world,s most pressing and evolving health needs. Our innovative ...
(Date:7/22/2014)... Terry Baughn, a senior lecturer in mechanical engineering at ... Engineer of the Year by the North Texas section ... ASME has more than 130,000 members in 158 countries ... technology to assist the engineering community, benefiting the world. ... Texas Society of Professional Engineers honors banquet. Baughn retired ...
(Date:7/22/2014)... July 22, 2014 Automated cell culture ... maintenance of cell culture. They allow production of optimum ... of researchers in drug discovery and industries and biopharmaceutical ... mAb production, iPSC research, cryobanking, cell-based assays, and cellular ... risk. , Analysts forecast the Global Cell Culture ...
(Date:7/22/2014)... OHAUS Corporation, a leading worldwide manufacturer ... scales, proudly announces its Explorer line of analytical ... 2014 “Readers' Choice” Award for best balance. ... was voted the best laboratory balance by the ... “excellence in product design and performance for the ...
Breaking Biology Technology:UT Dallas professor receives Engineer of the Year award 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 2Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 3Global Cell Culture Market to Grow at 10.27% CAGR by 2018 Forecasts a New Research Report ReportsnReports.com 4OHAUS Explorer Voted “Best Balance” in Laboratory Equipment’s 2014 Readers’ Choice Awards 2
... Ganeden Biotech announced the sale of ... brands of probiotic dietary supplements to Schiff ...  Ganeden will also receive royalties on Schiff products containing ... rights to use Ganeden,s probiotic technology, GanedenBC30™, in the ...
... SHENZHEN, China, June 4, 2011 To aid the ... strain in Europe, BGI-Shenzhen and their collaborators at the ... genome assembly result built upon the sequencing data previously ... days. As one of the first genomes assembled using ...
... N.C., June 3, 2011 Recent biopharmaceutical product launches ... the cardiovascular therapeutic area. Faced with a continually evolving ... the biggest role in the current launch environment. ... explores the pivotal success factors and failure points facing ...
Cached Biology Technology:Ganeden Biotech Completes $40 Million Sale of Sustenex® and Digestive Advantage® Probiotic Brands 2Ganeden Biotech Completes $40 Million Sale of Sustenex® and Digestive Advantage® Probiotic Brands 3Further Analysis on Improved Genome Assembly Indicates the Outbreak E. coli has Complex Genetics With Resistance to at Least Eight Antibiotics 2Further Analysis on Improved Genome Assembly Indicates the Outbreak E. coli has Complex Genetics With Resistance to at Least Eight Antibiotics 3Creating a Road Map for Successful Cardiovascular New Product Launch 2
(Date:7/22/2014)... A probiotic that prevents obesity could be on ... in the gut inhibit weight gain, insulin resistance ... in mice, Vanderbilt University investigators have discovered., "Of ... human," said senior investigator Sean Davies, Ph.D., assistant ... of the negative consequences of obesity in mice, ...
(Date:7/22/2014)... New Rochelle, NY -- Stem cells offer much promise ... transplantation approaches stem cell survival is poor, limiting their ... improve the survival and optimize their therapeutic function after ... BioResearch Open Access , a peer-reviewed journal from Mary ... on the BioResearch Open Access website ...
(Date:7/22/2014)... Curtin University-led research has shown squirrels have adapted to ... just as well, if not better, than their fellow ... Lecturer at Curtin,s Department of Environment & Agriculture, led ... to modify their behaviour in urban environments and prevent ... such as staying on the footpath. , "As ...
Breaking Biology News(10 mins):Vanderbilt study shows therapeutic bacteria prevent obesity in mice 2New York squirrels are nuts about city life 2
... Using satellite data, scientists have produced a first-of-its kind map ... are other local- and regional-scale forest canopy maps, the new ... on one uniform method. The map, based on data ... scientists build an inventory of how much carbon the world,s ...
... Spanish . Two good tips for preventing ... troughs and add chlorine to the water. That,s according ... the agency,s Animal Waste Management Research Unit in Bowling Green, ... a hydrologist at Bowling Green, and other colleagues. Stainless ...
... in French . Men who had a history ... cancer, according to a study carried out by researchers at INRSInstitut ... Montral, and McGill University. The findings, published in the Annals ... had a lower risk of lung cancer while those with a ...
Cached Biology News:First-of-its-kind map details the height of the globe's forests 2Dairy farmers can fight growing disease threat with chlorine and stainless steel 2Asthma and eczema sufferers have a lower risk of developing a cancer 2
biotin-4-fluorescein...
... the LVF-HL, LVF-CUVADPT, FHS-LVF, and the CVD-Diffuse ... low-pass Linear Variable Filters to create the ... center wavelength and adjustable bandpass. Each filter ... blocking band (99.8%). These filters -- ...
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
Request Info...
Biology Products: